Article
Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.
Oncotarget - 16 Feb 2016
Li Wenbin, Zhang Zhihui, Guo Lei, Qiu Tian, Ling Yun, Cao Jian, Guo Huiqin, Zhao Huan, Li Lin, Ying Jianming
Abstract excerpt
To investigate the use of molecular testing on cytological specimens in selecting advanced non-small cell lung cancer (NSCLC) patients who are adequate for targeted treatment, a total of 137 NSCLC cases were analyzed by fluorescence in situ hybridization (FISH) for anaplastic lymphoma kinase (ALK) rearrangements, and Epidermal growth factor receptor (EGFR), kirsten rat sarcoma viral oncogene homolog (KRAS)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
